首页 正文

Tropomyosin receptor kinase inhibitors: a patent update 2009 - 2013

{{output}}
Introduction: Tropomyosin receptor kinases (Trks) are a family of three similar tyrosine kinases activated by peptide hormones of the neurotrophin family. The nerve growth factor antibody tanezumab has provided clinical proof of ... ...